These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28570655)

  • 1. Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis.
    Li Z; Lin B; Lin G; Wu Y; Jie Y; Li X; Ko B; Chong Y; Luo J
    PLoS One; 2017; 12(6):e0178580. PubMed ID: 28570655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of Circulating FGF19 and Bile Acids in Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome.
    Li Z; Liu Y; Yang F; Pang J; Wu Y; Chong Y; Li X
    Biomed Res Int; 2020; 2020():1934541. PubMed ID: 32626734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of hepatic Fibroblast Growth Factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the disease.
    Wunsch E; Milkiewicz M; Wasik U; Trottier J; Kempińska-Podhorodecka A; Elias E; Barbier O; Milkiewicz P
    Sci Rep; 2015 Aug; 5():13462. PubMed ID: 26293907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis.
    Schaap FG; van der Gaag NA; Gouma DJ; Jansen PL
    Hepatology; 2009 Apr; 49(4):1228-35. PubMed ID: 19185005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cholecystectomy on bile acid synthesis and circulating levels of fibroblast growth factor 19.
    Barrera F; Azócar L; Molina H; Schalper KA; Ocares M; Liberona J; Villarroel L; Pimentel F; Pérez-Ayuso RM; Nervi F; Groen AK; Miquel JF
    Ann Hepatol; 2015; 14(5):710-21. PubMed ID: 26256900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of bile acid metabolism in biliary atresia: reduction of FGF19 by Kasai portoenterostomy and possible relation to early outcome.
    Johansson H; Svensson JF; Almström M; Van Hul N; Rudling M; Angelin B; Nowak G; Fischler B; Ellis E
    J Intern Med; 2020 May; 287(5):534-545. PubMed ID: 31976601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
    Friedrich D; Marschall HU; Lammert F
    BMC Gastroenterol; 2018 Jun; 18(1):76. PubMed ID: 29866129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.
    Lundåsen T; Gälman C; Angelin B; Rudling M
    J Intern Med; 2006 Dec; 260(6):530-6. PubMed ID: 17116003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental regulation of the gut-liver (FGF19-CYP7A1) axis in neonates.
    Memon N; Griffin IJ; Lee CW; Herdt A; Weinberger BI; Hegyi T; Carayannopoulos MO; Aleksunes LM; Guo GL
    J Matern Fetal Neonatal Med; 2020 Mar; 33(6):987-992. PubMed ID: 30122083
    [No Abstract]   [Full Text] [Related]  

  • 10. Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis.
    Brandl K; Hartmann P; Jih LJ; Pizzo DP; Argemi J; Ventura-Cots M; Coulter S; Liddle C; Ling L; Rossi SJ; DePaoli AM; Loomba R; Mehal WZ; Fouts DE; Lucey MR; Bosques-Padilla F; Mathurin P; Louvet A; Garcia-Tsao G; Verna EC; Abraldes JG; Brown RS; Vargas V; Altamirano J; Caballería J; Shawcross D; Stärkel P; Ho SB; Bataller R; Schnabl B
    J Hepatol; 2018 Aug; 69(2):396-405. PubMed ID: 29654817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An FXR Agonist Reduces Bile Acid Synthesis Independently of Increases in FGF19 in Healthy Volunteers.
    Al-Khaifi A; Rudling M; Angelin B
    Gastroenterology; 2018 Oct; 155(4):1012-1016. PubMed ID: 29928896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study.
    Appleby RN; Moghul I; Khan S; Yee M; Manousou P; Neal TD; Walters JRF
    PLoS One; 2019; 14(1):e0211348. PubMed ID: 30682184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nontumorigenic variant of FGF19 treats cholestatic liver diseases.
    Luo J; Ko B; Elliott M; Zhou M; Lindhout DA; Phung V; To C; Learned RM; Tian H; DePaoli AM; Ling L
    Sci Transl Med; 2014 Jul; 6(247):247ra100. PubMed ID: 25080475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19.
    Gälman C; Angelin B; Rudling M
    J Intern Med; 2011 Dec; 270(6):580-8. PubMed ID: 22003820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerostin Expression in Bile Ducts of Patients With Chronic Cholestasis May Influence the Bone Disease in Primary Biliary Cirrhosis.
    Guañabens N; Ruiz-Gaspà S; Gifre L; Miquel R; Peris P; Monegal A; Dubrueil M; Arias A; Parés A
    J Bone Miner Res; 2016 Sep; 31(9):1725-33. PubMed ID: 27019303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge.
    Zweers SJ; de Vries EM; Lenicek M; Tolenaars D; de Waart DR; Koelfat KV; Groen AK; Olde Damink SW; Beuers U; Ponsioen C; Jansen PL; Schaap FG
    Hepatol Int; 2017 Jan; 11(1):132-140. PubMed ID: 27696157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
    Chen W; Wei Y; Xiong A; Li Y; Guan H; Wang Q; Miao Q; Bian Z; Xiao X; Lian M; Zhang J; Li B; Cao Q; Fan Z; Zhang W; Qiu D; Fang J; Gershwin ME; Yang L; Tang R; Ma X
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):25-38. PubMed ID: 30900136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of Hepatic Bile Acid Synthesis by a non-tumorigenic FGF19 analogue Protects Mice from Fibrosis and Hepatocarcinogenesis.
    Gadaleta RM; Scialpi N; Peres C; Cariello M; Ko B; Luo J; Porru E; Roda A; Sabbà C; Moschetta A
    Sci Rep; 2018 Nov; 8(1):17210. PubMed ID: 30464200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis.
    Byun S; Kim DH; Ryerson D; Kim YC; Sun H; Kong B; Yau P; Guo G; Xu HE; Kemper B; Kemper JK
    Nat Commun; 2018 Jul; 9(1):2590. PubMed ID: 29968724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chenodeoxycholic Acid Modulates Bile Acid Synthesis Independent of Fibroblast Growth Factor 19 in Primary Human Hepatocytes.
    Johansson H; Søndergaard JN; Jorns C; Kutter C; Ellis ECS
    Front Endocrinol (Lausanne); 2020; 11():554922. PubMed ID: 33692750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.